PeerView Clinical Pharmacology CME/CNE/CPE Video

Prof. Chantal Mathieu, MD, PhD - Betting on Basal Insulin: Improving the Odds for People With Type 2 Diabetes

Tanios Bekaii-Saab, MD, FACP, FASCO - Raising the Game in Biliary Cancer: Adapting Rapidly Emerging Evidence and Achieving Optimal Disease Control With FGFR-Targeted Platforms

Joyce O'Shaughnessy, MD - Raising the Bar for Survival in High-Risk HR+, HER2- EBC: A Practical Framework for the Adjuvant Setting; Real-World Strategies to Improve Risk Assessment, Candidate Identification, Differentiated CDK4/6i + ET Selection, and Optimal Treatment Delivery

Yelena Y. Janjigian, MD*, Marion Liu, MD - Unifying Surgical-Oncology Expertise in Resectable Gastric/GEJ Malignancies: Leveraging the Evidence on Perioperative Immunotherapy Platforms to Deliver Personalized Care

Laura S. Dominici, MD, FACS - Lighting the Path in Early Breast Cancer Care: Uniting Evidence, Expertise, and Multidisciplinary Action

Hope S. Rugo, MD, FASCO - From Evidence to Impact: Harnessing PI3K/AKT/mTOR Pathway Inhibitors to Improve Outcomes in HR+, HER2- MBC; Shedding Light on Mechanisms, Clinical Evidence, and Adverse Event Management

Mrinal Gounder, MD - Paving the Path Forward for Desmoid Tumors: Multidisciplinary Tactics to Effectively Implement Gamma Secretase Inhibitors in Clinical Practice

Philip J. Mease, MD, MACR - Targeting Unmet Needs in Psoriatic Arthritis: Cases in Achieving Treatment Goals With TYK2 Inhibition

Ellen R. Sher, MD - A Life Less Stuffy for Patients With Perennial Allergic Rhinitis: Exploring Targeted Treatment Approaches to Improve Quality of Life

Michael R. Gieske, MD, Nichole T. Tanner, MD, MSCR - Real-World Strategies and Workflows for Lung Cancer Screening Success in Diverse Populations: Enhancing Vigilance to Increase Early Detection on the Front Lines of Care

Peter A. Campochiaro, MD / Diana V. Do, MD - Innovations in Retinal Vascular Diseases: Enhancing Patient Outcomes Through Longer-Acting Therapies and Precision Dosing

Dana M. Chase, MD, FACOG - Charting New Territories in Endometrial Cancer Care: Insights for Personalizing Treatment With Biomarker-Informed Therapies

Brooke E. Howitt, MD / Kathleen N. Moore, MD, MS, FASCO - Pathway to Precision in Ovarian Cancer: A Pathology-Informed Guide to Translating Biomarker Testing Results Into Actionable Treatment With ADCs

Heather A. Wakelee, MD, FASCO, Helena A. Yu, MD - Data and Decisions in Advanced NSCLC: Addressing Open Questions to Optimize Immunotherapy and Targeted Options

Amit Bar-Or, MD, FRCPC, FAAN, FANA / Tanuja Chitnis, MD, MA, FAAN, FANA - Neuroinflammation in Focus: Interpreting the Latest Evidence for BTK Inhibition in Multiple Sclerosis

Juan Fortea, MD, PhD / Professor Frank Jessen, MD - Strategies for Appropriate Assessment and Use of APOE Status in Alzheimer’s Disease: Clinical Care in Europe

Barbara Burtness, MD - New Immunotherapy Frontiers in R/M HNSCC: Multidisciplinary Perspectives on Advancing Care in Challenging Patient Populations

Cecelia Damask, DO - Building on the Path in CRSwNP: Targeting Upstream Drivers With the Latest Biologic Approaches

Robert (Bob) J. Fox, MD, Jiwon Oh, MD, PhD, FRCPC - Disease and Disability Progression in Relapsing MS: Unpacking Efficacy Data to Advance Treatment Decisions

Samuel Cytryn, MD / Daniela Molena, MD / Manish A. Shah, MD, FASCO - Synchronizing Success in Resectable Gastric/GEJ Cancer: Merging Expertise to Effectively Deliver Immunotherapy Platforms in the Surgical Setting

Seema S. Aceves, MD, PhD - Smoothing the Way in Eosinophilic Esophagitis: Targeted, Team-Based Strategies for Pediatric and Adult Care

Aarti Bhatia, MD, MPH / Deborah J. Wong, MD, PhD - Immune Innovation in Head and Neck Cancer: Insights on Checkpoint Inhibitors and Bispecifics Across Disease Settings

Toby Maher, MD, MSc, PhD - Rethinking Pulmonary Fibrosis: From Fine-Tuning Diagnosis to Illuminating Novel Pathways for Emerging Treatment Strategies

Suzanne E. Schindler, MD, PhD - Preparing for the New Era of Blood-Based Biomarkers in Alzheimer’s Disease: Navigating Guidelines, Understanding Policy, and Integrating Into Practice Workflows

Roxana Mehran, MD / Jeffrey Weitz, MD, FRCPC, FRSC, FACP - Navigating the Path to Next-Generation Anticoagulation Strategies: Rising to the Challenge of Unmet Needs in SSP and AF

Ana C. Garrido-Castro, MD - TROP2-Targeting ADCs in the Forefront: Changing Standards and Best Practices in TNBC and HR+, HER2- Breast Cancer Care

Anju T. Peters, MD, MS, Michael Platt, MD, MSc - Treating With Precision in CRSwNP: Defining the Role of Targeted Biologic Therapy for Optimal Patient Outcomes

Thomas Grader-Beck, MD - Sjögren’s Disease and the B-Cell Frontier: What Clinicians Need to Know Now to Prepare for Future Therapies

Prof. Kevin J. Harrington, FCRP, FRCR, FRSB, PhD / Prof. Christophe Le Tourneau, MD, PhD - Staying Current on Immunotherapy for HNSCC: Conversations on Clinical Collaboration and Treatment Selection

Phillip H. Kuo, MD, PhD / Jonathan E. McConathy, MD, PhD, FSNMMI - Alzheimer’s Disease Case Conference: Building Confidence in Visual Interpretation and Quantitative Analysis of Neuroimaging

Simron Singh, MD, MPH - Catalysts for Enhanced Patient CARE In Neuroendocrine Neoplasms: Clinical Adoption of Rapidly Emerging Evidence on Novel Therapeutic Strategies

Lauren A. Byers, MD - The ADC Wave in SCLC: Emerging Evidence and Practical Considerations for New Options on the Horizon

Prof. Dr. Peter R. Galle - Streamlining Multidirectional Care in HCC: Applying Groundbreaking Evidence on Systemic Treatment Approaches Across the Disease Spectrum

Brooke Looney, PharmD, CSP / Alicia K. Morgans, MD, MPH, FASCO - Paving the Path for Optimal Prostate Cancer Care: Preparing Advanced Practice Providers to Integrate Modern Therapies Into Tailored Treatment Plans

Nicole Lamanna, MD, Lydia Scarfò, MD - Choices, Changes, and Global Perspectives in CLL Care: Real-World Insights and New Evidence on Finite Therapy With Targeted Agents

MeiLan K. Han, MD, MS / Fernando J. Martinez, MD, MS - ECHOing Innovation in COPD: Transforming Patient Care With the Use of Targeted Biologic Therapy

Jaume Capdevila, MD, PhD - From Poor Prognosis to Emerging Clinical Potential: A Visual Journey of Targeted Therapy Innovation in Extrapulmonary Neuroendocrine Carcinomas

Elizabeth R. Volkmann, MD, MS - Frameworks for Identifying Systemic Sclerosis and Its Complications: From Pathophysiology to Personalized Care

Asuncion Mejias, MD, PhD - RSV Prophylaxis Unveiled: What Healthcare Providers Need to Know

Benjamin C. Creelan, MD - Taking the High Road in NSCLC: Navigating Through Immunotherapy-Based Treatments to Optimize Outcomes

Stephen V. Liu, MD - Innovation Takes the Lead in SCLC: Leveraging Evolving Advances to Drive Improved Outcomes in Limited- and Extensive-Stage Disease

Nicola Gökbuget, MD - Moving Forward in B-ALL: Insights on Modern and Emerging Standards With Off-the-Shelf Bispecific Antibodies

Prof. Solange Peters, MD, PhD / Prof. David Planchard, MD, PhD - The Challenges of Choice in First-Line EGFRm NSCLC: Practical Guidance on Optimising Treatment Approaches

Sia Daneshmand, MD - Elevating NMIBC Care: Putting the Latest Innovations for Intravesical Therapies Into Practice

Prof. Eric Van Cutsem, MD, PhD - Precision Tactics With HER2-Targeting ADCs in HER2-Altered Solid Tumors: Candid Conversations and Clinical Consults

Komal Jhaveri, MD, FACP - Dialing Up Precision in HR+, HER2- MBC With New Endocrine Agents, Targeted Therapies, and Combinations: A Framework for Multifactorial Clinical Decisions

Prof. Dr. Max S. Topp, MD - Off the Shelf and in the Clinic for NHL: Leveraging Bispecific Antibody Strategies in DLBCL, FL, and Beyond

Professor John G. Gribben, MD, DSc - Pathways to Personalized Remission in CLL: Leveraging Targeted Standards and Next-Gen Advances for Upfront and Sequential Care

David A. Sallman, MD - Menin Masters for AML Care: Guidance on Integrating Menin Inhibitor Regimens and Boosting Efficacy in Challenging AML Subtypes

Joyce O'Shaughnessy, MD - Forging New Paths With Earlier Use of ADCs in Breast Cancer: From Clinical Breakthroughs to Improved Outcome